Article
Radiomics using contrast-enhanced T1-weighted imaging and clinical features for predicting response to EGFR-TKI in EGFR-mutated non-small cell lung cancer patients with brain metastases
2026-02-17
Abstract excerpt
<title>Abstract</title> <p>Objectives To construct and validate a model based on clinical characteristics and magnetic resonance imaging (MRI) radiomics to predict 1-year efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in patients with EGFR-mutant non-small cell lung cancer (NSCLC) brain metastases (BMs). Methods This study retrospectively analyzed data from 338 patients with...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eaa6547e-d54f-5e89-9dd7-e6252d429085
- DOI
- 10.21203/rs.3.rs-8521529/v1
